145 related articles for article (PubMed ID: 32427017)
1. Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia.
Fulcher J; Leung E; Christou G; Bredeson C; Sabloff M
Leuk Lymphoma; 2020 Sep; 61(9):2271-2273. PubMed ID: 32427017
[No Abstract] [Full Text] [Related]
2. Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.
Ivanov V; Farnault L; Mercier C; Colavolpe C; Venton G; Colle J; Lepidi H; Arnoux I; Nicolino-Brunet C; Berda-Haddad Y; Fanciullino R; Ivanov G; Costello R
Leuk Lymphoma; 2020 May; 61(5):1230-1233. PubMed ID: 31900013
[No Abstract] [Full Text] [Related]
3. How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
Frey NV; Luger SM
Blood; 2015 Jul; 126(5):589-96. PubMed ID: 25966988
[TBL] [Abstract][Full Text] [Related]
4. Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B-acute lymphoblastic leukaemia.
Collignon C; Domenech C; Ducassou S; Pluchart C; Bruno B; Pasquet M; Simon P; Petit A; Rialland-Battisti F; Brethon B
Br J Haematol; 2023 May; 201(4):e42-e45. PubMed ID: 36971071
[No Abstract] [Full Text] [Related]
5. [Optimized treatment of childhood B-lineage acute lymphoblastic leukemia].
Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Apr; 25(4):344-349. PubMed ID: 37073837
[TBL] [Abstract][Full Text] [Related]
6. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
[No Abstract] [Full Text] [Related]
7. Cobalamin deficiency during treatment of pediatric precursor B-cell acute lymphoblastic leukemia.
Kinoshita H; Watanabe A; Taji Y; Yoshimura M; Ohta A; Fukushima T; Tanaka R; Ebihara Y
Pediatr Blood Cancer; 2021 Dec; 68(12):e29258. PubMed ID: 34302713
[No Abstract] [Full Text] [Related]
8. Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series.
Grigoleit GU; Kapp M; Tan SM; Unzicker C; Einsele H; Mielke S; Topp MS; Stuhler G
Leuk Lymphoma; 2009 Dec; 50(12):2071-4. PubMed ID: 19886845
[No Abstract] [Full Text] [Related]
9. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Gururangan S; Horner M; Rodman JH; Marina NM
Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
[TBL] [Abstract][Full Text] [Related]
10. How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy.
Aldoss I; Forman SJ
Blood; 2020 Mar; 135(11):804-813. PubMed ID: 31899793
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Einsiedel HG; Kawan L; Eckert C; Witt O; Fichtner I; Henze G; Seeger K
Leukemia; 2006 Aug; 20(8):1435-6. PubMed ID: 16810202
[No Abstract] [Full Text] [Related]
12. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
[No Abstract] [Full Text] [Related]
13. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.
Bertaina A; Vinti L; Strocchio L; Gaspari S; Caruso R; Algeri M; Coletti V; Gurnari C; Romano M; Cefalo MG; Girardi K; Trevisan V; Bertaina V; Merli P; Locatelli F
Br J Haematol; 2017 Feb; 176(4):629-636. PubMed ID: 28116786
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
15. Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia.
Bergeron BP; Barnett KR; Bhattarai KR; Mobley RJ; Hansen BS; Brown A; Kodali K; High AA; Jeha S; Pui CH; Peng J; Pruett-Miller SM; Savic D
Blood Adv; 2023 Aug; 7(15):4107-4111. PubMed ID: 37289547
[No Abstract] [Full Text] [Related]
16. [Clinical characteristics and prognosis of various immunocytological subvariants of acute lymphoblastic leukemia in children].
Klubovskaia NI; Tsveĭbakh AS; Petrova EM; Pustovalova AG; Bessonova AG
Pediatriia; 1989; (2):30-4. PubMed ID: 2726363
[TBL] [Abstract][Full Text] [Related]
17. FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia.
O'Leary MC; Lu X; Huang Y; Lin X; Mahmood I; Przepiorka D; Gavin D; Lee S; Liu K; George B; Bryan W; Theoret MR; Pazdur R
Clin Cancer Res; 2019 Feb; 25(4):1142-1146. PubMed ID: 30309857
[TBL] [Abstract][Full Text] [Related]
18. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
19. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
Mullighan CG
Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
